The heavy atom effect on thiadiazolo[3,4-g]quinoxaline derivatives as novel photosensitizers for photodynamic therapy

Xianqiang Li; Li-Peng Zhang; Yuxia Zhao

doi:10.1117/12.2538821

20 November 2019 The heavy atom effect on thiadiazolo[3,4-g]quinoxaline derivatives as novel photosensitizers for photodynamic therapy

Xianqiang Li, Li-Peng Zhang, Yuxia Zhao

Author Affiliations +

Proceedings Volume 11190, Optics in Health Care and Biomedical Optics IX; 1119015 (2019) https://doi.org/10.1117/12.2538821
Event: SPIE/COS Photonics Asia, 2019, Hangzhou, China

Abstract

Two novel thiadiazolo[3,4-g]quinoxaline (TQ) derivatives, 6,7-bis(4-(hexyloxy)phenyl)-[1,2,5]thiadiazolo[3,4- g]quinoxaline (TQs-1) and 4,9-dibromo-6,7-bis(4-(hexyloxy)phenyl)-[1,2,5]thiadiazolo[3,4-g]quinoxaline (TQs-2) were synthesized and fully characterized by 1H-NMR, 13C-NMR and HR-MS spectra. Their photo-physical and photo-chemical properties, including UV-Vis spectra, fluorescence spectra, photostability and singlet oxygen quantum yield were comprehensively studied. Compared to TQs-1, TQs-2 exhibited a higher singlet oxygen quantum yield and a broader absorption spectrum due to the introduction of two bromine atoms. Furthermore, TQs-2 based nanoparticles (TQs-2 NPs) was obtained via a simple co-assembly strategy using a biocompatible amphiphilic polymer DSPE-mPEG2000 to encapsulate TQs-2. In vitro photodynamic therapy (PDT) experiments to three tumor cells (4T1, MCF-7 and HeLa) and normal cells (L929) were carried out using TQs-2 NPs as photosensitizers. The results showed that TQs-2 NPs possessed negligible dark cytotoxicity to these cells at a high concentration of 50 μg mL-1, but exhibited high light cytotoxicity to them, especially to three tumor cells, under a 532 nm laser illumination at the same concentration, indicating that TQs-2 NPs has a promising potential for PDT applications.

Citation Download Citation

Xianqiang Li, Li-Peng Zhang, and Yuxia Zhao "The heavy atom effect on thiadiazolo[3,4-g]quinoxaline derivatives as novel photosensitizers for photodynamic therapy", Proc. SPIE 11190, Optics in Health Care and Biomedical Optics IX, 1119015 (20 November 2019); https://doi.org/10.1117/12.2538821

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available